JW (Cayman) Therapeutics Co Ltd
HKEX:2126
JW (Cayman) Therapeutics Co Ltd
PP&E Gross
JW (Cayman) Therapeutics Co Ltd
PP&E Gross Peer Comparison
Competitive PP&E Gross Analysis
Latest Figures & CAGR of Competitors
Company | PP&E Gross | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
JW (Cayman) Therapeutics Co Ltd
HKEX:2126
|
PP&E Gross
¥381m
|
CAGR 3-Years
7%
|
CAGR 5-Years
38%
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
PP&E Gross
¥9.3B
|
CAGR 3-Years
54%
|
CAGR 5-Years
54%
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
PP&E Gross
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
PP&E Gross
¥2.9B
|
CAGR 3-Years
46%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
PP&E Gross
¥5.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
PP&E Gross
¥279.5m
|
CAGR 3-Years
22%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
See Also
What is JW (Cayman) Therapeutics Co Ltd's PP&E Gross?
PP&E Gross
381m
CNY
Based on the financial report for Dec 31, 2023, JW (Cayman) Therapeutics Co Ltd's PP&E Gross amounts to 381m CNY.
What is JW (Cayman) Therapeutics Co Ltd's PP&E Gross growth rate?
PP&E Gross CAGR 5Y
38%
Over the last year, the PP&E Gross growth was 0%. The average annual PP&E Gross growth rates for JW (Cayman) Therapeutics Co Ltd have been 7% over the past three years , 38% over the past five years .